APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasma Therapy

Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.

Selected research

Market Outlook & Growth Opportunities

Global Plasma Therapy Market Outlook and Growth Opportunities 2026

19 December 2025199 pages

Choose your research edition.

Industry ResearchPlasma Therapy Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma Therapy Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Plasma Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma Therapy Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma Therapy Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.

North America is the largest consumption place, with a consumption market share nearly 53% . Europe is the second largest consumption place with the consumption market share of 26%. Terumo, Arthrex, Zimmer Biomet, DePuy Synthes and EmCyte are the leaders of the industry, top 3 companies occupied about 55% market share.

This report provides an overview of the global Plasma Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Plasma Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plasma Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Plasma Therapy market.

Plasma Therapy Segment by Company

Terumo

Arthrex

Zimmer Biomet

DePuy Synthes

EmCyte

Regen Lab

ISTO Biologics

Cesca Therapeutics

Weigao

REV-MED

Nuo Therapeutics

Plasma Therapy Segment by Type

Pure PRP

Leucocyte-rich PRP

Leukocyte-rich Fibrin (L-PRF)

Plasma Therapy Segment by Application

Orthopedic

Darmatology

Cardiac Muscle Injury

Dental

Nerve Injury

Plasma Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Plasma Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Plasma Therapy key companies, revenue, market share, and recent developments.

3. To split the Plasma Therapy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Plasma Therapy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Plasma Therapy significant trends, drivers, influence factors in global and regions.

6. To analyze Plasma Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plasma Therapy industry.

Chapter 3: Detailed analysis of Plasma Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Plasma Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Plasma Therapy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Plasma Therapy Industry Trends Table 2. Plasma Therapy Industry Drivers Table 3. Plasma Therapy Industry Opportunities and Challenges Table 4. Plasma Therapy Industry Restraints Table 5. Global Plasma Therapy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Plasma Therapy Revenue Share by Company (2021-2026) Table 7. Global Plasma Therapy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Plasma Therapy Key Company Manufacturing Base & Headquarters Table 9. Global Plasma Therapy Company, Product Type & Application Table 10. Global Plasma Therapy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Plasma Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Pure PRP Table 15. Significant Companies of Leucocyte-rich PRP Table 16. Significant Companies of Leukocyte-rich Fibrin (L-PRF) Table 17. Global Plasma Therapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Plasma Therapy Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Plasma Therapy Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Plasma Therapy Sales Value Share by Type (2021-2026) Table 21. Global Plasma Therapy Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Orthopedic Table 23. Significant Companies of Darmatology Table 24. Significant Companies of Cardiac Muscle Injury Table 25. Significant Companies of Dental Table 26. Significant Companies of Nerve Injury Table 27. Global Plasma Therapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Plasma Therapy Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Plasma Therapy Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Plasma Therapy Sales Value Share by Application (2021-2026) Table 31. Global Plasma Therapy Sales Value Share by Application (2027-2032) Table 32. Global Plasma Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Plasma Therapy Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Plasma Therapy Sales Value Share by Region (2021-2026) Table 35. Global Plasma Therapy Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Plasma Therapy Sales Value Share by Region (2027-2032) Table 37. Global Plasma Therapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Plasma Therapy Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Plasma Therapy Sales Value Market Share by Country (2021-2026) Table 40. Global Plasma Therapy Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Plasma Therapy Sales Value Market Share by Country (2027-2032) Table 42. Terumo Company Information Table 43. Terumo Business Overview Table 44. Terumo Plasma Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Terumo Plasma Therapy Product Portfolio Table 46. Terumo Recent Development Table 47. Arthrex Company Information Table 48. Arthrex Business Overview Table 49. Arthrex Plasma Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Arthrex Plasma Therapy Product Portfolio Table 51. Arthrex Recent Development Table 52. Zimmer Biomet Company Information Table 53. Zimmer Biomet Business Overview Table 54. Zimmer Biomet Plasma Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Zimmer Biomet Plasma Therapy Product Portfolio Table 56. Zimmer Biomet Recent Development Table 57. DePuy Synthes Company Information Table 58. DePuy Synthes Business Overview Table 59. DePuy Synthes Plasma Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. DePuy Synthes Plasma Therapy Product Portfolio Table 61. DePuy Synthes Recent Development Table 62. EmCyte Company Information Table 63. EmCyte Business Overview Table 64. EmCyte Plasma Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. EmCyte Plasma Therapy Product Portfolio Table 66. EmCyte Recent Development Table 67. Regen Lab Company Information Table 68. Regen Lab Business Overview Table 69. Regen Lab Plasma Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Regen Lab Plasma Therapy Product Portfolio Table 71. Regen Lab Recent Development Table 72. ISTO Biologics Company Information Table 73. ISTO Biologics Business Overview Table 74. ISTO Biologics Plasma Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. ISTO Biologics Plasma Therapy Product Portfolio Table 76. ISTO Biologics Recent Development Table 77. Cesca Therapeutics Company Information Table 78. Cesca Therapeutics Business Overview Table 79. Cesca Therapeutics Plasma Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Cesca Therapeutics Plasma Therapy Product Portfolio Table 81. Cesca Therapeutics Recent Development Table 82. Weigao Company Information Table 83. Weigao Business Overview Table 84. Weigao Plasma Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Weigao Plasma Therapy Product Portfolio Table 86. Weigao Recent Development Table 87. REV-MED Company Information Table 88. REV-MED Business Overview Table 89. REV-MED Plasma Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. REV-MED Plasma Therapy Product Portfolio Table 91. REV-MED Recent Development Table 92. Nuo Therapeutics Company Information Table 93. Nuo Therapeutics Business Overview Table 94. Nuo Therapeutics Plasma Therapy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Nuo Therapeutics Plasma Therapy Product Portfolio Table 96. Nuo Therapeutics Recent Development Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Plasma Therapy Product Image Figure 2. Global Plasma Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasma Therapy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Pure PRP Image Figure 8. Leucocyte-rich PRP Image Figure 9. Leukocyte-rich Fibrin (L-PRF) Image Figure 10. Global Plasma Therapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Plasma Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Plasma Therapy Sales Value Share by Type (2021-2032) Figure 13. Orthopedic Image Figure 14. Darmatology Image Figure 15. Cardiac Muscle Injury Image Figure 16. Dental Image Figure 17. Nerve Injury Image Figure 18. Global Plasma Therapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Plasma Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Plasma Therapy Sales Value Share by Application (2021-2032) Figure 21. Global Plasma Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Plasma Therapy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Plasma Therapy Sales Value (2021-2032) & (US$ Million) Figure 24. North America Plasma Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Plasma Therapy Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Plasma Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Plasma Therapy Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Plasma Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Plasma Therapy Sales Value (2021-2032) & (US$ Million) Figure 30. South America Plasma Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Plasma Therapy Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Plasma Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Plasma Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Plasma Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Plasma Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Pure PRP
  • Leucocyte-rich PRP
  • Leukocyte-rich Fibrin (L-PRF)
Applications
  • Orthopedic
  • Darmatology
  • Cardiac Muscle Injury
  • Dental
  • Nerve Injury
Companies covered
  • Terumo
  • Arthrex
  • Zimmer Biomet
  • DePuy Synthes
  • EmCyte
  • Regen Lab
  • ISTO Biologics
  • Cesca Therapeutics
  • Weigao
  • REV-MED
  • Nuo Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Plasma Therapy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Plasma Therapy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Plasma Therapy Market Dynamics
  1. 2.1 Plasma Therapy Industry Trends
  2. 2.2 Plasma Therapy Industry Drivers
  3. 2.3 Plasma Therapy Industry Opportunities and Challenges
  4. 2.4 Plasma Therapy Industry Restraints
3 Plasma Therapy Market by Company
  1. 3.1 Global Plasma Therapy Company Revenue Ranking in 2025
  2. 3.2 Global Plasma Therapy Revenue by Company (2021-2026)
  3. 3.3 Global Plasma Therapy Company Ranking (2024-2026)
  4. 3.4 Global Plasma Therapy Company Manufacturing Base and Headquarters
  5. 3.5 Global Plasma Therapy Company Product Type and Application
  6. 3.6 Global Plasma Therapy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Plasma Therapy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Plasma Therapy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Plasma Therapy Market by Type
  1. 4.1 Plasma Therapy Type Introduction
  2. 4.1.1 Pure PRP
  3. 4.1.2 Leucocyte-rich PRP
  4. 4.1.3 Leukocyte-rich Fibrin (L-PRF)
  5. 4.2 Global Plasma Therapy Sales Value by Type
  6. 4.2.1 Global Plasma Therapy Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Plasma Therapy Sales Value by Type (2021-2032)
  8. 4.2.3 Global Plasma Therapy Sales Value Share by Type (2021-2032)
5 Plasma Therapy Market by Application
  1. 5.1 Plasma Therapy Application Introduction
  2. 5.1.1 Orthopedic
  3. 5.1.2 Darmatology
  4. 5.1.3 Cardiac Muscle Injury
  5. 5.1.4 Dental
  6. 5.1.5 Nerve Injury
  7. 5.2 Global Plasma Therapy Sales Value by Application
  8. 5.2.1 Global Plasma Therapy Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Plasma Therapy Sales Value by Application (2021-2032)
  10. 5.2.3 Global Plasma Therapy Sales Value Share by Application (2021-2032)
6 Plasma Therapy Regional Value Analysis
  1. 6.1 Global Plasma Therapy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plasma Therapy Sales Value by Region (2021-2032)
  3. 6.2.1 Global Plasma Therapy Sales Value by Region: 2021-2026
  4. 6.2.2 Global Plasma Therapy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Plasma Therapy Sales Value (2021-2032)
  7. 6.3.2 North America Plasma Therapy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Plasma Therapy Sales Value (2021-2032)
  10. 6.4.2 Europe Plasma Therapy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Plasma Therapy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Plasma Therapy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Plasma Therapy Sales Value (2021-2032)
  16. 6.6.2 South America Plasma Therapy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Plasma Therapy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Plasma Therapy Sales Value Share by Country, 2025 VS 2032
7 Plasma Therapy Country-level Value Analysis
  1. 7.1 Global Plasma Therapy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Plasma Therapy Sales Value by Country (2021-2032)
  3. 7.2.1 Global Plasma Therapy Sales Value by Country (2021-2026)
  4. 7.2.2 Global Plasma Therapy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Plasma Therapy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Plasma Therapy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Plasma Therapy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Plasma Therapy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Plasma Therapy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Plasma Therapy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Plasma Therapy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Plasma Therapy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Plasma Therapy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Plasma Therapy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Plasma Therapy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Plasma Therapy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Plasma Therapy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Plasma Therapy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Plasma Therapy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Plasma Therapy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Plasma Therapy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Plasma Therapy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Plasma Therapy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Plasma Therapy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Plasma Therapy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Plasma Therapy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Plasma Therapy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Plasma Therapy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Plasma Therapy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Plasma Therapy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Plasma Therapy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Plasma Therapy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Plasma Therapy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Plasma Therapy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Plasma Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Terumo
  2. 8.1.1 Terumo Company Information
  3. 8.1.2 Terumo Business Overview
  4. 8.1.3 Terumo Plasma Therapy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Terumo Plasma Therapy Product Portfolio
  6. 8.1.5 Terumo Recent Developments
  7. 8.2 Arthrex
  8. 8.2.1 Arthrex Company Information
  9. 8.2.2 Arthrex Business Overview
  10. 8.2.3 Arthrex Plasma Therapy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Arthrex Plasma Therapy Product Portfolio
  12. 8.2.5 Arthrex Recent Developments
  13. 8.3 Zimmer Biomet
  14. 8.3.1 Zimmer Biomet Company Information
  15. 8.3.2 Zimmer Biomet Business Overview
  16. 8.3.3 Zimmer Biomet Plasma Therapy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zimmer Biomet Plasma Therapy Product Portfolio
  18. 8.3.5 Zimmer Biomet Recent Developments
  19. 8.4 DePuy Synthes
  20. 8.4.1 DePuy Synthes Company Information
  21. 8.4.2 DePuy Synthes Business Overview
  22. 8.4.3 DePuy Synthes Plasma Therapy Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DePuy Synthes Plasma Therapy Product Portfolio
  24. 8.4.5 DePuy Synthes Recent Developments
  25. 8.5 EmCyte
  26. 8.5.1 EmCyte Company Information
  27. 8.5.2 EmCyte Business Overview
  28. 8.5.3 EmCyte Plasma Therapy Revenue and Gross Margin (2021-2026)
  29. 8.5.4 EmCyte Plasma Therapy Product Portfolio
  30. 8.5.5 EmCyte Recent Developments
  31. 8.6 Regen Lab
  32. 8.6.1 Regen Lab Company Information
  33. 8.6.2 Regen Lab Business Overview
  34. 8.6.3 Regen Lab Plasma Therapy Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Regen Lab Plasma Therapy Product Portfolio
  36. 8.6.5 Regen Lab Recent Developments
  37. 8.7 ISTO Biologics
  38. 8.7.1 ISTO Biologics Company Information
  39. 8.7.2 ISTO Biologics Business Overview
  40. 8.7.3 ISTO Biologics Plasma Therapy Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ISTO Biologics Plasma Therapy Product Portfolio
  42. 8.7.5 ISTO Biologics Recent Developments
  43. 8.8 Cesca Therapeutics
  44. 8.8.1 Cesca Therapeutics Company Information
  45. 8.8.2 Cesca Therapeutics Business Overview
  46. 8.8.3 Cesca Therapeutics Plasma Therapy Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cesca Therapeutics Plasma Therapy Product Portfolio
  48. 8.8.5 Cesca Therapeutics Recent Developments
  49. 8.9 Weigao
  50. 8.9.1 Weigao Company Information
  51. 8.9.2 Weigao Business Overview
  52. 8.9.3 Weigao Plasma Therapy Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Weigao Plasma Therapy Product Portfolio
  54. 8.9.5 Weigao Recent Developments
  55. 8.10 REV-MED
  56. 8.10.1 REV-MED Company Information
  57. 8.10.2 REV-MED Business Overview
  58. 8.10.3 REV-MED Plasma Therapy Revenue and Gross Margin (2021-2026)
  59. 8.10.4 REV-MED Plasma Therapy Product Portfolio
  60. 8.10.5 REV-MED Recent Developments
  61. 8.11 Nuo Therapeutics
  62. 8.11.1 Nuo Therapeutics Company Information
  63. 8.11.2 Nuo Therapeutics Business Overview
  64. 8.11.3 Nuo Therapeutics Plasma Therapy Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nuo Therapeutics Plasma Therapy Product Portfolio
  66. 8.11.5 Nuo Therapeutics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst